Presynaptic α2-adrenoceptors control the inhibitory action of presynaptic CB1 cannabinoid receptors on prefrontocortical norepinephrine release in the rat

Neuropharmacology

Volumn 63, Issue 5, 2012, Pages 784-797

  Richter, Hardy ^a,b   Teixeira, Filipe M ^c   Ferreira, Samira G ^c   Kittel, Ágnes ^a   Köfalvi, Attila ^c   Sperlágh, Beáta ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

2A adrenergic receptor; CB1 receptor; Norepinephrine; Prefrontal cortex; Release

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CANNABINOID 1 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; DEPRESSION; ELECTROSTIMULATION; FORCED SWIMMING TEST; MALE; MOUSE; NEUROMODULATION; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; PREFRONTAL CORTEX; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

ADRENERGIC FIBERS; ANIMALS; BEHAVIOR, ANIMAL; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR ANTAGONISTS; CEREBRUM; DEPRESSION; DOWN-REGULATION; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NOREPINEPHRINE; ORGAN SPECIFICITY; OSMOLAR CONCENTRATION; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 84864451017     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.06.003     Document Type: Article

References (72)

1. C. Aoki, C.G. Go, C. Venkatesan, and H. Kurose Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity Brain Res. 650 1994 181 204 (Pubitemid 24207063)
2. C. Aoki, C. Venkatesan, C.G. Go, R. Forman, and H. Kurose Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons Cereb. Cortex 8 1998 269 277 (Pubitemid 28226163)
3. A.F. Arnsten, J.X. Cai, and P.S. Goldman-Rakic The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes J. Neurosci. 8 1988 4287 4298 (Pubitemid 19017410)
4. A.F. Arnsten Catecholamine influences on dorsolateral prefrontal cortical networks Biol. Psychiatry 69 12 2011 e89 99
5. F.R. Bambico, N. Katz, G. Debonnel, and G. Gobbi Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex J. Neurosci. 27 2007 11700 11711 (Pubitemid 350006914)
6. A.L. Bodor, I. Katona, G. Nyiri, K. Mackie, C. Ledent, N. Hajos, and T.F. Freund Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types J. Neurosci. 25 2005 6845 6856 (Pubitemid 41023152)
7. M.G. Bossong, and R.J. Niesink Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia Prog. Neurobiol. 92 3 2010 370 385
8. F.P. Bymaster, J.S. Katner, D.L. Nelson, S.K. Hemrick-Luecke, P.G. Threlkeld, J.H. Heiligenstein, S.M. Morin, D.R. Gehlert, and K.W. Perry Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 2002 699 711 (Pubitemid 35335888)
9. F.P. Bymaster, W. Zhang, P.A. Carter, J. Shaw, E. Chernet, L. Phebus, D.T. Wong, and K.W. Perry Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex Psychopharmacology (Berl) 160 2002 353 361 (Pubitemid 34253277)
10. P.M. Canas, J.M. Duarte, R.J. Rodrigues, A. Köfalvi, and R.A. Cunha Modification upon aging of the density of presynaptic modulation systems in the hippocampus Neurobiol. Aging 30 2009 1877 1884
11. A.F. Carvalho, K. Mackie, and E.J. Van Bockstaele Cannabinoid modulation of limbic forebrain noradrenergic circuitry Eur. J. Neurosci. 31 2010 286 301
12. P.J. Conn, and B.L. Roth Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settings Neuropsychopharmacology 33 2008 2048 2060 (Pubitemid 351992094)
13. Y. Cordeaux, and S.J. Hill Mechanisms of cross-talk between G-protein-coupled receptors Neurosignals 11 2002 45 57 (Pubitemid 37499849)
14. J.F. Cryan, and A. Holmes The ascent of mouse: advances in modelling human depression and anxiety Nat. Rev. Drug Discov. 4 2005 775 790 (Pubitemid 43090498)
15. J.F. Cryan, A. Markou, and I. Lucki Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol. Sci. 23 2002 238 245 (Pubitemid 34465544)
16. C. Csölle, A. Heinrich, A. Kittel, and B. Sperlagh P2Y receptor mediated inhibitory modulation of noradrenaline release in response to electrical field stimulation and ischemic conditions in superfused rat hippocampus slices J. Neurochem. 106 2008 347 360 (Pubitemid 351840215)
17. 1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling Neuropharmacology 54 2008 36 44 (Pubitemid 350299401)
18. 1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism J. Neurochem. 106 2008 70 82 (Pubitemid 351840192)
19. L. Degenhardt, W. Hall, and M. Lynskey The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being Soc. Psychiatry Psychiatr. Epidemiol. 36 2001 219 227 (Pubitemid 32694466)
20. E. Drews, M. Schneider, and M. Koch Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats Pharmacol. Biochem. Behav. 80 2005 145 150 (Pubitemid 40126212)
21. K. Dzirasa, H.W. Phillips, T.D. Sotnikova, A. Salahpour, S. Kumar, R.R. Gainetdinov, M.G. Caron, and M.A. Nicolelis Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony J. Neurosci. 30 18 2010 May 5 6387 6397
22. 1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function J. Biol. Chem. 281 2006 38812 38824 (Pubitemid 46042008)
23. 1 cannabinoid receptors control frontocortical serotonin and glutamate release - species differences. Neurochem. Int., in press.
24. P. Fries Neuronal gamma-band synchronization as a fundamental process in cortical computation Annu. Rev. Neurosci. 32 2009 209 224
25. Y. Fukudome, T. Ohno-Shosaku, M. Matsui, Y. Omori, M. Fukaya, H. Tsubokawa, M.M. Taketo, M. Watanabe, T. Manabe, and M. Kano Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling Eur. J. Neurosci. 19 2004 2682 2692 (Pubitemid 38746385)
26. K. Fuxe, D.O. Borroto-Escuela, D. Marcellino, W. Romero-Fernandez, M. Frankowska, D. Guidolin, M. Filip, L. Ferraro, A.S. Woods, A. Tarakanov, F. Ciruela, L.F. Agnati, and S. Tanganelli GPCR heteromers and their allosteric receptor-receptor interactions Curr. Med. Chem. 19 2012 356 363
27. N.J. Gamo, and A.F. Arnsten Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders Behav. Neurosci. 125 3 2011 282 296
28. I. Gobel, A.U. Trendelenburg, S.L. Cox, A. Meyer, and K. Starke Electrically evoked release of [(3)H]noradrenaline from mouse cultured sympathetic neurons: release-modulating heteroreceptors J. Neurochem. 75 2000 2087 2094
29. 1 receptor antagonist rimonabant in models of emotional reactivity in rodents Biol. Psychiatry 57 2005 261 267 (Pubitemid 40187370)
30. M. Hajós, W.E. Hoffmann, and B. Kocsis Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia Biol. Psychiatry 63 2008 1075 1083
31. J. Haller, I. Barna, B. Barsvari, K. Gyimesi Pelczer, S. Yasar, L.V. Panlilio, and S. Goldberg Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats Psychopharmacology (Berl) 204 2009 607 616
32. 1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: a comparison between the gray mouse lemur (Microcebus murinus, primates) and rat Neuroscience 135 2005 595 609 (Pubitemid 41317395)
33. 1 receptor activity elicits an antidepressant-like response in the rat forced swim test Eur. Neuropsychopharmacol. 15 2005 593 599 (Pubitemid 41587409)
34. 1 cannabinoid receptor J. Neurochem. 73 2 1999 493 501 (Pubitemid 29339821)
35. 1 receptors on peripheral sympathetic nerves Br. J. Pharmacol. 118 1996 2023 2028 (Pubitemid 26292572)
36. O. Jensen, J. Kaiser, and J.P. Lachaux Human gamma-frequency oscillations associated with attention and memory Trends Neurosci. 30 2007 317 324 (Pubitemid 46991117)
37. W. Jiang, Y. Zhang, L. Xiao, J. Van Cleemput, S.P. Ji, G. Bai, and X. Zhang Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects J. Clin. Invest. 115 2005 3104 3116 (Pubitemid 41567575)
38. 1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain Naunyn Schmiedebergs Arch. Pharmacol. 359 1999 466 470 (Pubitemid 29302618)
39. G. Koob, and M.J. Kreek Stress, dysregulation of drug reward pathways, and the transition to drug dependence Am. J. Psychiatry 164 8 2007 1149 1159 (Pubitemid 47292402)
40. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology 35 2010 217 238
41. M. Lafourcade, I. Elezgarai, S. Mato, Y. Bakiri, P. Grandes, and O.J. Manzoni Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex PLoS One 2 2007 e709
42. 1 receptor knockout mice Science 283 1999 401 404
43. K.H. Lee, L.M. Williams, M. Breakspear, and E. Gordon Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia Brain Res. Brain Res. Rev. 41 2003 57 78 (Pubitemid 36044594)
44. K. Mackie Cannabinoid receptor homo- and heterodimerization Life Sci. 77 2005 1667 1673
45. D.T. Malone, M.N. Hill, and T. Rubino Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models Br. J. Pharmacol. 160 3 2010 511 522
46. G. Milligan G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function Br. J. Pharmacol. 158 2009 5 14
47. G. Navarro, S. Ferré, A. Cordomi, E. Moreno, J. Mallol, V. Casadó, A. Cortés, H. Hoffmann, J. Ortiz, E.I. Canela, C. Lluís, L. Pardo, R. Franco, and A.S. Woods Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers J. Biol. Chem. 285 2010 27346 27359
48. S.E. Nissen, S.J. Nicholls, K. Wolski, J. Rodes-Cabau, C.P. Cannon, J.E. Deanfield, J.P. Despres, J.J. Kastelein, S.R. Steinhubl, S. Kapadia, M. Yasin, W. Ruzyllo, C. Gaudin, B. Job, B. Hu, D.L. Bhatt, A.M. Lincoff, and E.M. Tuzcu Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial JAMA 299 2008 1547 1560 (Pubitemid 351482794)
49. V.C. Oropeza, K. Mackie, and E.J. Van Bockstaele Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex Brain Res. 1127 2007 36 44 (Pubitemid 44854843)
50. V.C. Oropeza, M.E. Page, and E.J. Van Bockstaele Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex Brain Res. 1046 2005 45 54 (Pubitemid 40775873)
51. M.E. Page, V.C. Oropeza, and E.J. Van Bockstaele Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex Neurosci. Lett. 431 2008 1 5
52. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates, fourth Ed 1998 Academic Press New York
53. B. Ramos, and A. Arnsten Adrenergic pharmacology and cognition: focus on the prefrontal cortex Pharmacol. Ther. 113 3 2007 523 536 (Pubitemid 46365960)
54. B.A. Reyes, J.C. Rosario, P.M. Piana, and E.J. Van Bockstaele Cannabinoid modulation of cortical adrenergic receptors and transporters J. Neurosci. Res. 87 2009 3671 3678
55. 1 receptors Acta Pol. Pharm. 61 2004 165 167 (Pubitemid 40515126)
56. E. Schlicker, and M. Gothert Interactions between the presynaptic alpha2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones Brain Res. Bull. 47 1998 129 132 (Pubitemid 28502853)
57. E. Schlicker, and M. Kathmann Modulation of transmitter release via presynaptic cannabinoid receptors Trends Pharmacol. Sci. 22 2001 565 572 (Pubitemid 33042646)
58. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus Naunyn Schmiedebergs Arch. Pharmacol. 356 1997 583 589 (Pubitemid 27478960)
59. 1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta Naunyn Schmiedebergs Arch. Pharmacol. 372 2005 139 146 (Pubitemid 41504161)
60. 1 receptor inverse agonist AM251 in mice Behav. Pharmacol. 14 2003 573 582
61. R. Stadel, K.H. Ahn, and D.A. Kendall The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail J. Neurochem. 117 2011 1 18
62. K. Starke Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors J. Neurochem. 78 2001 685 693 (Pubitemid 32777970)
63. E. Takahashi, M. Katayama, K. Niimi, and C. Itakura Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests Eur. J. Pharmacol. 589 2008 149 156
64. 1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions Br. J. Pharmacol. 138 2003 544 553 (Pubitemid 36315302)
65. M. Uchigashima, M. Narushima, M. Fukaya, I. Katona, M. Kano, and M. Watanabe Subcellular arrangement of molecules for 2-arachidonoyl-glycerol- mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum J. Neurosci. 27 2007 3663 3676 (Pubitemid 46557660)
66. C.J. van Koppen, and K.H. Jakobs Arrestin-independent internalization of G protein-coupled receptors Mol. Pharmacol. 66 2004 365 367 (Pubitemid 39329234)
67. 1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors J. Neurosci. 19 1999 9271 9280 (Pubitemid 30228080)
68. M.P. Viveros, E.M. Marco, and S.E. File Endocannabinoid system and stress and anxiety responses Pharmacol. Biochem. Behav. 81 2005 331 342 (Pubitemid 40807131)
69. M. Wang, B.P. Ramos, C.D. Paspalas, Y. Shu, A. Simen, A. Duque, S. Vijayraghavan, A. Brennan, A. Dudley, E. Nou, J.A. Mazer, D.A. McCormick, and A.F. Arnsten Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex Cell 129 2007 397 410 (Pubitemid 46574970)
70. B.H. Westerink, Y. Kawahara, P. De Boer, C. Geels, J.B. De Vries, H.V. Wikstrom, A. Van Kalkeren, Van Vliet, C.G. Kruse, and S.K. Long Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum Eur. J. Pharmacol. 412 2001 127 138 (Pubitemid 32124859)
71. H.T. Zhang, L.R. Whisler, Y. Huang, Y. Xiang, and J.M. O'Donnell Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior Neuropsychopharmacology 34 2009 1067 1077
72. W. Zhang, K.W. Perry, D.T. Wong, B.D. Potts, J. Bao, G.D. Tollefson, and F.P. Bymaster Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex Neuropsychopharmacology 23 2000 250 262 (Pubitemid 30609659)